Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study

Autor: Hawkins, Randall, Roy, A, Cunningham, D, Sörbye, H, Adenis, A, Barcelo, J-R, Lopez-Vivanco, G, Adler, G, Canon, J-L, Lofts, F
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Zdroj: Hawkins, Randall; Roy, A; Cunningham, D; Sörbye, H; Adenis, A; Barcelo, J-R; et al.(2012). Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study.. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/08r1583f
Popis: Docetaxel and irinotecan chemotherapy have shown good efficacy in the treatment of advanced oesophago-gastric cancer. This randomised phase II study evaluated the efficacy and toxicity profile of two non-platinum docetaxel-based doublet regimens in advance
Databáze: OpenAIRE